BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19124612)

  • 1. Bezafibrate at clinically relevant doses decreases serum/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor alpha-independent mechanism.
    Nakajima T; Tanaka N; Kanbe H; Hara A; Kamijo Y; Zhang X; Gonzalez FJ; Aoyama T
    Mol Pharmacol; 2009 Apr; 75(4):782-92. PubMed ID: 19124612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
    Nakajima T; Tanaka N; Li G; Hu R; Kamijo Y; Hara A; Aoyama T
    Redox Rep; 2010; 15(3):123-30. PubMed ID: 20594415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin increases hepatic triglyceride content through upregulation of SREBP-1c activity.
    Yan F; Wang Q; Lu M; Chen W; Song Y; Jing F; Guan Y; Wang L; Lin Y; Bo T; Zhang J; Wang T; Xin W; Yu C; Guan Q; Zhou X; Gao L; Xu C; Zhao J
    J Hepatol; 2014 Dec; 61(6):1358-64. PubMed ID: 25016220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering effect of bezafibrate is independent of peroxisome proliferator-activated receptor activation in mice.
    Nakajima T; Tanaka N; Sugiyama E; Kamijo Y; Hara A; Hu R; Li G; Li Y; Nakamura K; Gonzalez FJ; Aoyama T
    Biochem Pharmacol; 2008 Jul; 76(1):108-19. PubMed ID: 18486101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eicosapentaenoic acid improves hepatic steatosis independent of PPARα activation through inhibition of SREBP-1 maturation in mice.
    Tanaka N; Zhang X; Sugiyama E; Kono H; Horiuchi A; Nakajima T; Kanbe H; Tanaka E; Gonzalez FJ; Aoyama T
    Biochem Pharmacol; 2010 Nov; 80(10):1601-12. PubMed ID: 20691165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic PGC-1beta overexpression induces combined hyperlipidemia and modulates the response to PPARalpha activation.
    Lelliott CJ; Ljungberg A; Ahnmark A; William-Olsson L; Ekroos K; Elmgren A; Arnerup G; Shoulders CC; Oscarsson J; Lindén D
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2707-13. PubMed ID: 17932310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARdelta agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet.
    Nagasawa T; Inada Y; Nakano S; Tamura T; Takahashi T; Maruyama K; Yamazaki Y; Kuroda J; Shibata N
    Eur J Pharmacol; 2006 Apr; 536(1-2):182-91. PubMed ID: 16574099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor alpha is required for feedback regulation of highly unsaturated fatty acid synthesis.
    Li Y; Nara TY; Nakamura MT
    J Lipid Res; 2005 Nov; 46(11):2432-40. PubMed ID: 16106047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling.
    Hu XQ; Wang YM; Wang JF; Xue Y; Li ZJ; Nagao K; Yanagita T; Xue CH
    Lipids Health Dis; 2010 Mar; 9():25. PubMed ID: 20211032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
    Ren T; Zhu J; Zhu L; Cheng M
    Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
    Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
    Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion.
    Pettinelli P; Del Pozo T; Araya J; Rodrigo R; Araya AV; Smok G; Csendes A; Gutierrez L; Rojas J; Korn O; Maluenda F; Diaz JC; Rencoret G; Braghetto I; Castillo J; Poniachik J; Videla LA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1080-6. PubMed ID: 19733654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chrysanthemum morifolium extract attenuates high-fat milk-induced fatty liver through peroxisome proliferator-activated receptor α-mediated mechanism in mice.
    Cui Y; Wang X; Xue J; Liu J; Xie M
    Nutr Res; 2014 Mar; 34(3):268-75. PubMed ID: 24655494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
    Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
    Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with the modified Longdan Xiegan Tang attenuates olanzapine-induced fatty liver in rats by regulating hepatic de novo lipogenesis and fatty acid beta-oxidation-associated gene expression mediated by SREBP-1c, PPAR-alpha and AMPK-alpha.
    Ren L; Sun D; Zhou X; Yang Y; Huang X; Li Y; Wang C; Li Y
    J Ethnopharmacol; 2019 Mar; 232():176-187. PubMed ID: 30590197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
    Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hepatic sterol regulatory element-binding protein-1c-mediated gene expression contributes to Salacia oblonga root-elicited improvement of fructose-induced fatty liver in rats.
    Liu L; Yang M; Lin X; Li Y; Liu C; Yang Y; Yamahara J; Wang J; Li Y
    J Ethnopharmacol; 2013 Dec; 150(3):1045-52. PubMed ID: 24157375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.